Physician profile
Hemal Bhatt
NPI 1255621447
$26,031.39
in general payments reported to CMS, 2019-2025
25 companies · $1,732 in 2025
The $1,732 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $22K · 2021: $323 · 2022: $99.10 · 2023: $251 · 2024: $469 · 2025: $1,732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,555 · Travel and Lodging: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,555.02 |
| Travel and Lodging | $896.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $21,154.41 | 2020 | |
| Abbott Laboratories | $1,641.46 | 2019-2025 | Triclip, Navitor |
| Abiomed | $726.85 | 2019-2025 | Impella |
| Penumbra, INC. | $453.45 | 2020-2025 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $282.15 | 2019-2024 | Avvigo Guidance System, Watchman Access System |
| Edwards Lifesciences Corporation | $257.94 | 2021-2025 | Evoque |
| Cardiovascular Systems INC. | $201.77 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $170.63 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $163.78 | 2021-2025 | Gore Cardioform Septal Occluder |
| Philips North America LLC | $143.16 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $124.95 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.78 | 2020-2022 | |
| Inari Medical, INC. | $103.79 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $94.18 | 2020 | |
| Cook Medical LLC | $77.16 | 2022-2023 | Advance, Tornado |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $59.34 | 2020 | |
| Janssen Pharmaceuticals, INC | $57.09 | 2020 | |
| Heartflow, INC. | $34.84 | 2019 | |
| Merit Medical Systems INC | $32.90 | 2020 | |
| Amgen INC. | $30.62 | 2023-2024 | Repatha |
| Shockwave Medical, INC | $22.35 | 2020 | |
| Novartis Pharmaceuticals Corporation | $21.90 | 2020 | |
| Chiesi USA, INC. | $18.97 | 2025 | Kengreal |
| Angiodynamics, INC. | $18.29 | 2021 | |
| Pfizer INC. | $16.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemal Bhatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.